Data source | Sensitivity*% | Specificity†% | Sensitivity*% | Specificity†% | False detection rate‡% |
---|
| Weekly | Daily | Weekly | Daily |
---|
EMD-AT | (3/9) | (5/8) | (5/67) | (53/56) | (3/6) | (3/8) |
33.3
|
62.5
|
7.5
|
94.6
|
50.0
|
37.5
|
EP-AT | (0/9) | (8/8) | (0/67) | (56/56) | (0/0) | (0/0) |
0.0
|
100.0
|
0.0
|
100.0
| | |
EP-BE | (6/10) | (6/7) | (12/70) | (51/53) | (1/7) | (2/14) |
60.0
|
85.7
|
17.1
|
96.2
|
14.3
|
14.3
|
ED-BE | (10/10) | (4/7) | (26/70) | (45/53) | (3/13) | (8/34) |
100.0
|
57.1
|
37.1
|
84.9
|
23.1
|
23.5
|
ED-ES | (6/8) | (8/9) | (30/56) | (63/67) | (1/7) | (4/34) |
|
75.0
|
88.9
|
53.6
|
94.0
|
14.3
|
11.8
|
- *Brackets: Number of weeks / days with at least one true-positive Poisson CUSUM signal in syndromic surveillance data divided by number of pandemic weeks/days according to reference data.
-
†Brackets: Number of true-negative weeks / days (no Poisson CUSUM signal) in syndromic surveillance data divided by number of weeks / days outside the pandemic period according to reference data.
-
‡Brackets: Number of weeks/days with a false-positive Poisson CUSUM signal in syndromic surveillance data divided by all Poisson CUSUM signals of syndromic surveillance data.